Biodistribution and oxidative stress effects of a systemically-introduced commercial ceria engineered nanomaterial

Nanotoxicology

Volumn 3, Issue 3, 2009, Pages 234-248

  Yokel, Robert A ^a   Florence, Rebecca L ^a   Unrine, Jason M ^b   Tseng, Michael T ^d   Graham, Uschi M ^a   Wu, Peng ^c   Grulke, Eric A ^c   Sultana, Rukhsana ^a   Hardas, Sarita S ^a   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d University of Louisville School of Medicine   (United States)

Author keywords

Blood brain barrier; Ceria; Neurotoxicity; Oxidative injury; Rat

Indexed keywords

3 NITROTOLUENE; 4 HYDROXYNONENAL; ALBUMIN; CERIUM OXIDE; EVANS BLUE; FLUORESCEIN SODIUM; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD BRAIN BARRIER; CONTROLLED STUDY; HALF LIFE TIME; HIPPOCAMPUS; MALE; NANOTOXICOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT; RETICULOENDOTHELIAL SYSTEM; TISSUE DISTRIBUTION; TOXICOKINETICS; TRANSMISSION ELECTRON MICROSCOPY;

RATTUS;

EID: 72449144275     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.1080/17435390902974496     Document Type: Article

References (74)

1. Asati A, Santra S, Kaittanis C, Nath S, Perez JM. 2009. Oxidaselike activity of polymer-coated cerium oxide. Angewandte Chemie 48:2308-2312.
2. Aksenov MY, Aksenova MV, Carney J, Butterfield DA. 1997. Oxidative modification of glutamine synthetase by amyloid beta peptide. Free Radical Res 27:267-281.
3. Aksenov M, Aksenova M, Butterfield DA,Markesbery WR. 2000. Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J Neurochem 74:2520-2527.
4. Bai J, Xu Z, Zheng Y, Yin H. 2006. Shape control of CeO2 nanostructure materials in microemulsion systems. Materials Lett 6:1287-1290.
5. Biozzi G, Benacerraf B, Halpern BN. 1953. Quantitative study of the granulopectic activity of the reticulo-endothelial system. II. A study of the kinetics of the R. E. S. in relation to the dose of carbon injected; relationship between the weight of the organs and their activity. Br J Exp Pathol 34:441-457.
6. Brigger I, Morizet J, Laudani L, Aubert G, Appel M, Velasco V, Terrier-Lacombe MJ, Desmaele D, d'Angelo J, Couvreur P, Vassal G. 2004. Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model. J Contr Release 100:29-40.
7. Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK, Bruinink A, Stark WJ. 2006. In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Tech 40:4374-4381.
8. Butterfield DA. 1997. beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem Res Toxicol 10:495-506.
9. Butterfield DA, Stadtman ER. 1997. Protein oxidation processes in aging brain. Adv Cell Aging Gerontol 2:161-191.
10. Butterfield DA, Lauderback CM. 2002. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid b-peptide-associated free radical oxidative stress. Free Radic Biol Med 32:1050-1060.
11. Butterfield DA, Reed T, Newman SF, Sultana R. 2007. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 43:658-677.
12. Chen C, Zhang P, Chai Z. 2001. Distribution of some rare earth elements and their binding species with proteins in human liver studied by instrumental neutron activation analysis combined with biochemical techniques. Anal Chim Acta 439:19-27.
13. Chen J, Patil S, Seal S, McGinnis JF. 2006. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 1:142-150.
14. Das M, Patil S, Bhargava N, Kang JF, Riedel LM, Seal S, Hickman JJ. 2007. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomat 28:1918-1925.
15. Davies JC. 2006. Managing the effects of nanotechnology. Project on emerging nanotechnologies, Woodrow Wilson International Center for Scholars.
16. Demoy M, Andreux JP, Weingarten C, Gouritin B, Guilloux V, Couvreur P. 1999. Spleen capture of nanoparticles: Influence of animal species and surface characteristics. Pharm Res 16: 37-41.
17. Fenart L, Casanova A, Dehouck B, Duhem C, Slupek S, Cecchelli R, Betbeder D. 1999. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. J Pharmacol Exp Ther 291:1017-1022.
18. Feng X, Sayle DC, Wang ZL, Paras MS, Santora B, Sutorik AC, Sayle TX, Yang Y, Ding Y, Wang X, Her YS. 2006. Converting ceria polyhedral nanoparticles into single-crystal nanospheres. Science 312:1504-1508.
19. Ferin J, Oberdörster G, Penney DP. 1992. Pulmonary retention of ultrafine and fine particles in rats. Am J Resp Cell Mol Biol 6:535-542.
20. Ferin J, Oberdörster G, Penney DP, Soderholm SC, Gelein R, Piper HC. 1990. Increased pulmonary toxicity of ultrafine particles? I. Particle clearance, translocation, morphology. J Aerosol Sci 21:381-384.
21. Fox JL, Lamson ML. 1989. RSTRIP: Pharmacokinetic data stripping/least squares parameter optimization, MicroMath, Inc., Salt Lake City, UT, USA.
22. Gao K, Jiang X. 2006. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80- coated polybutylcyanoacrylate nanoparticles. Int J Pharmaceut 310:213-219.
23. Han W-Q, Wu L, Wang X, Zhu Y, Rodriguez JA. 2006. Characterization of CeO2-x nanotubes by HRTEM, EELS and XANES. 231st ACS National Meeting, Atlanta, GA, USA.
24. Hawkins BT, Egleton RD. 2006. Fluorescence imaging of bloodbrain barrier disruption. J Neurosci Meth 151:262-267.
25. Health Effects Institute (HEI). 2001. Evaluation of human health risk from cerium added to diesel fuel. HEI Communication 9, Boston, MA, USA.
26. Integrated Laboratory Systems Inc. 2006. Chemical information profile for ceric oxide [CAS No. 1306-38-3]. Supporting Nomination for Toxicological Evaluation by the National Toxicology Program. In: National Toxicology Program, NIEHS, Research Triangle Park, NC, USA; p 21.
27. Jakupec MA, Unfried P, Keppler BK. 2005. Pharmacological properties of cerium compounds. Rev Physiol Biochem Pharmacol 153:101-111.
28. Joshi G, Hardas S, Sultana R, Vore M, St Clair D, Butterfield DA. 2007. Glutathione elevation by gamma-glutamylcysteine ethyl ester as a potential therapeutic strategy towards preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implications for chemobrain. J Neurosci Res 85:497-503.
29. Kabuto M, Kubota T, Kobayashi H, Ishii H, Nakagawa T, Kawai H, Kitai R, Kodera T, Kaneko M. 1997. Experimental study of detection of brain tumor at surgery using fluorescent imaging under a surgical microscope after fluorescein administration. Brain Nerve 49:261-265. (Pubitemid 27166532)
30. Koziara JM, Lockman PR, Allen DD, Mumper RJ. 2006. The blood-brain barrier and brain drug delivery. J Nanosci Nanotech 6:2712-2735.
31. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A. 2002. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 65:1513-1530.
32. Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, Butterfield DA. 2001. The glial transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: Role of Ab(1-42). J Neurochem 78:413-416.
33. Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ. 2005. Oxide nanoparticle uptake in human lung fibroblasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol 39:9370-9376.
34. Lin W, Huang YW, Zhou XD, Ma Y. 2006. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol 25:451-457. (Pubitemid 44885100)
35. Lockman PR, Koziara JM, Mumper RJ, Allen DD. 2004. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Targeting 12:635-641.
36. Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM,Maysinger D. 2005. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 83:377-385.
37. LutherW. 2004. Industrial application of nanomaterials-chances and risks. Technology analysis. Future Technologies Division of VDI Technologiezentrum GmbH, Dusseldorf, Germany.
38. Mai H-X, Sun L-D, Zhang Y-W, Si R, Feng W, Zhang H-P, Liu H-C, Yan C-H. 2005. Shape-selective synthesis and oxygen storage behavior of ceria nanopolyhedra, nanorods and nanocubes. J Phy Chem B 109:24380-24385.
39. Mamot C, Nguyen JB, Pourdehnad M, Hadaczek P, Saito R, Bringas JR, Drummond DC, Hong K, Kirpotin DB, McKnight T, Berger MS, Park JW, Bankiewicz KS. 2004. Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery. J Neurooncol 68:1-9.
40. Maynard AD. 2006. Nanotechnology: A research strategy for addressing risk. Project on emerging nanotechnologies, Woodrow Wilson International Center for Scholars.
41. Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622-627.
42. Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. 2002. Passage of inhaled particles into the blood circulation in humans. Circulation 105:411-414.
43. Niu J, Azfer A, Rogers LM, Wang X, Kolattukudy PE. 2007. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 73:549-559.
44. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. 2005a. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Particle Fibre Toxicol 2:35.
45. Oberdörster G, Oberdörster E, Oberdörster J. 2005b. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
46. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. 2002. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 65:1531-1543.
47. Park EJ, Choi J, Park YK, Park K. 2008. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicol 245:90-100.
48. Perluigi M, Sultana R, Cenini G, Di Domenico F, Memo M, Pierce WM, Coccia R, Butterfield DA. 2009. Redox proteomics identification of HNE-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics-Clin Appl, in press.
49. Poon HF, Calabrese V, Scapagnini G, Butterfield DA. 2004. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol A Biol Sci Med Sci 59:478-493.
50. Qi L, Sehgal A, Castaing J-C, Chapel J-P, Fresnais J, Berret J-F, Cousin F. 2008. Redispersible hybrid nanopowders: Cerium oxide nanoparticle complexes with phosphonated-PEG oligomers. ACS Nano 2:879-888.
51. Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, Butterfield DA. 2008. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 30: 107-120.
52. Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, Larsen A, Danscher G. 2007. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4:10.
53. Schubert D, Dargusch R, Raitano J, Chan SW. 2006. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Comm 342:86-91.
54. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG. 2004. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 16:453-459.
55. Si R, Zhang Y-W, You L-P, Yan C-H. 2005. Rare-earth oxide nanopolyhedra, nanoplates, and nanodisks. Angewandte Chemie. Int Ed 44:3256-3260.
56. Singh N, Cohen CA, Rzigalinski BA. 2007. Treatment of neurodegenerative disorders with radical nanomedicine. Ann NY Acad Sci 1122:219-230.
57. Skebo JE, Grabinski CM, Schrand AM, Schlager JJ, Hussain SM. 2007. Assessment of metal nanoparticle agglomeration, uptake, and interaction using high-illuminating system. Int J Toxicol 26:135-141.
58. Subramaniam R, Roediger F, Jordan B, Mattson MP, Keller JN, Waeg G, Butterfield DA. 1997. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J Neurochem 69: 1161-1169.
59. Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, Butterfield DA. 2005. Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)- induced oxidative stress and neurotoxicity: Relationship to antioxidant activity. J Neurochem 92:749-758.
60. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 109(Suppl. 4):547-551.
61. Tangpong J, Cole MP, Sultana R, Joshi G, Estus S, Vore M, St Clair W, Ratanachaiyavong D, St Clair D, Butterfield DA. 2006. Adriamycin-induced, TNF-mediated central nervous system toxicity. Neurobiol Dis 23:127-139.
62. Tangpong J, Cole MP, Sultana R, Estus S, Vore M, St Clair W, Ratanachaiyavong D, St Clair DK, Butterfield DA. 2007. Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: Insight into the mechanism of chemobrain. J Neurochem 100:191-201.
63. Tarnuzzer RW, Colon J, Patil S, Seal S. 2005. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett 5:2573-2577.
64. Thill A, Zeyons O, Spalla O, Chauvat F, Rose J, Auffan M, Flank AM. 2006. Cytotoxicity of CeO2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism. Environ Sci Technol 40:6151-6156.
65. Trovarelli A. 2002. Catalysis by ceria and related materials. London: Imperial College Press.
66. UK MNT Network (UK Micro Nano Technology Network) Nanoscale combustion catalyst reduces diesel consumption by up to 10%. Accessed 7 March 2009 from the website: http:// nanocentral.eu/uploads/downloads/nanoscalecombustion.pdf.
67. Unfried K, Albrecht C, Klotz L-O, von Mikecz A, Grether-Beck S, Schins RPF. 2007. Cellular responses to nanoparticles: Target structures and mechanisms. Nanotoxicology 1:52-71.
68. Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sugita M. 1988. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 8:282-284.
69. Wang CF, Hegsted DM. 1949. Normal blood volume, plasma volume and thiocyanate space in rats and their relation to body weight. Am J Physiol 156:218-226.
70. Warheit DB, Borm PJ, Hennes C, Lademann J. 2007. Testing strategies to establish the safety of nanomaterials: Conclusions of an ECETOC workshop. Inhal Toxicol 19:631-643.
71. Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi H, Yeh JI, Zink JI, Nel AE. 2008. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2: 2121-2134.
72. Yang S, Gao L. 2006. Controlled synthesis and self-assembly of CeO2 nanocubes. J Am Chem Soc 128:9330-9331.
73. Yu T, Joo J, Park YI, Hyeon T. 2005. Large-scale nonhydrolytic sol-gel synthesis of uniform-sized ceria nanocrystals with spherical, wire, and tadpole shapes. Angewandte Chemie, Int Ed 44:7411-7414.
74. Zhang F, Wang P, Koberstein J, Khalid S, Chan S-W. 2004. Cerium oxidation state in ceria nanoparticles studied with x-ray photoelectron spectroscopy and absorption near edge spectroscopy. Surface Sci 563:74-82.